baber/WOPTO huggingface dataset:
Patent EP-4182693-A2 (EP)
Inventor: MURRAY ANDREA
IPC: G01N33/574
Filed: 2021-07-14
Abstract: The present invention relates generally to the field of antibody detection, and in particular relates to methods involving the detection of autoantibodies relating to lung cancer in a sample comprising patient bodily fluid. In particular, the present invention relates to a method of detecting lung cancer in a mammalian subject by detecting three or more autoantibodies in a test sample, wherein three of the autoantibodies are immunologically specific for the tumour marker antigens p53, SSX1, and either p62 or KOC. The invention also relates to  in vitro  methods of determining an autoantibody profile, methods of diagnosing and treating lung cancer, methods of predicting response to a lung cancer treatment, use of a panel of three or more tumour marker antigens for the detection of lung cancer, and kits for the detection of autoantibodies.
Patent EP-4114922-A2 (EP)
Title: Regulating activation of fibroblasts to prevent fibrosis
Inventor: ALEXANIAN MICHAEL
IPC: C12N15/113
Filed: 2021-03-02
Abstract: Described herein are methods for treating cardiac conditions that include modulating Meox1 enhancer activity, Meox1 transcription, Meox1 translation, MEOX1 protein function, or a combination thereof. Also described herein are methods for identifying agents that can modulate Meox1 enhancer activity.
Patent EP-4214701-A2 (EP)
Inventor: JAIN ANKITA D
IPC: G10K11/178
Filed: 2021-09-16
Abstract: A noise-cancellation system with secondary path adaptation, includes: a noise-cancellation filter configured to receive a reference signal representative of a source of noise within a predefined volume and generating, based at least in part on the reference signal, a noise-cancellation signal that, when transduced by a speaker, produces a noise-cancellation acoustic signal that reduces noise in a cancellation zone within the predefined volume; a secondary path estimation filter configured to receive an input signal and to implement an estimate of secondary path transfer function, the secondary path transfer function being a transfer function between the speaker and a cancellation zone, the secondary path estimation filter outputting an output signal based, at least in part, on the estimate of the secondary path transfer function and the input signal; an adaptive module configured to adjust coefficients of the noise-cancellation filter according to a first adaptive algorithm, based, at least in part, on the estimated output signal; and an secondary path adaptive module configured to adjust coefficients of the secondary path estimation filter according to a second adaptive algorithm, wherein a rate of adaptation of the second adaptive algorithm is based, at least in part, on a coherence between the reference signal and an error signal representative of residual noise within the cancellation zone.
Patent EP-4092756-A2 (EP)
Inventor: IUCOLANO FERDINANDO
IPC: H01L29/423
Filed: 2018-06-08
Abstract: HEMT (1; 21; 31; 51) including a buffer layer (4), a hole-supply layer (6) on the buffer layer (4), a heterostructure (7) on the hole-supply layer (6), and a source electrode (16). The hole-supply layer (6) is made of P-type doped semiconductor material, the buffer layer (4) is doped with carbon, and the source electrode (16) is in direct electrical contact with the hole-supply layer (6), such that the hole-supply layer (6) can be biased to facilitate the transport of holes from the hole-supply layer (6) to the buffer layer (4) .
Patent EP-4314019-A2 (EP)
Inventor: LANGEDIJK JOHANNES PETRUS MARIA
IPC: C07K14/005
Filed: 2022-03-31
Abstract: The present invention relates to stabilized pre-fusion human parainfluenza virus 3 (HPIV3) F protein, and fragments thereof. The invention also relates to nucleic acid molecules encoding such proteins and fragments, and to the use of the proteins, fragments and nucleic acid molecules.
Patent EP-4219336-A2 (EP)
Inventor: COLLIER PAUL
IPC: B65D75/32
Filed: 2020-11-12
Abstract: A tamper evident package comprises a blister assembly defining at least one cavity, the opening of the at least one cavity being at least partially closed by a membrane. A sleeve housing the blister assembly is provided, the sleeve having a top side and a bottom side, the bottom side having a contact window that is aligned with the cavity. In addition, a package integrity feature is applied to the bottom side and covers the contact window. The package integrity feature is further applied to the membrane covering the cavity through the contact window.
Patent EP-4252855-A2 (EP)
Inventor: LEE PATRICE A
IPC: A61P35/04
Filed: 2013-03-25
Abstract: A solid dispersion comprising  N 4-(4-([1,2,4]Triazolo[1,5- a ]pyridin-7-yloxy)-3-methylphenyl)- N 6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine or amorphous (2-((4-((4-([1,2,4]triazolo[1,5- a ]pyridin-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)amino)-4-methyl-4,5-dihydrooxazol-4-yl)methanol and a dispersion polymer, for use in treating patients with ErbB2 positive metastatic breast cancer with brain metastases.
Patent EP-4236240-A2 (EP)
Title: Network anomaly detection
IPC: H04L41/14
Filed: 2019-11-22
Abstract: A computer implemented method comprising extracting one or more first features and an actual label from a first network control message collected from a network, predicting a predicted label for a second network control message collected from the network based on one or more second features extracted from the second network control message, the one or more second features being input to a predictive model that is trained based on the one or more first features and the actual label, and detecting a network anomaly of the network based on the predicted label.
Patent EP-4248848-A2 (EP)
Inventor: ZHANG YINGCHUN
IPC: A61B5/00
Filed: 2021-04-29
Abstract: A system for determining a treatment regimen for chronic pelvic pain (CPP) includes an electromyography (EMG) probe including electrodes. Each electrode detects pelvic floor muscle activity. An EMG sensor set includes bipolar EMG sensors configured to detect muscle activity of muscles connected to the pelvic floor muscles. An EMG amplifier is in communication with the EMG probe or the EMG sensor set. The EMG amplifier includes a plurality of input channels. Each input channel receives data of muscle activity in the pelvic floor muscles or the muscles connected to the pelvic floor muscles from the EMG probe or the EMG sensor set. A processor of a computer performs muscle network analysis using the data of muscle activity in the pelvic floor muscles or the muscles connected to the pelvic floor muscles. A treatment regimen for CPP is recommended based on the muscle network analysis.
Patent EP-4258635-A2 (EP)
Title: Enterprise access control and accounting allocation for access networks
Inventor: RALEIGH GREGORY G
IPC: H04M15/30
Filed: 2011-09-28
Abstract: Enterprise and consumer billing allocation for wireless communication device service usage activities is provided. In some embodiments, enterprise and consumer billing allocation for wireless communication device service usage activities includes monitoring a service usage activity of wireless communication device, and determining an enterprise and consumer billing allocation for the monitored service usage activity. In some embodiments, enterprise and consumer billing allocation for wireless communication device service usage activities includes monitoring a service usage activity of wireless communication device, and reporting the monitored service usage activity t a network element, in which the network element determines an enterprise and consumer billing allocation for the monitored service usage activity.
Patent EP-4246871-A2 (EP)
Inventor: HORIUCHI AYAKO
IPC: H04L5/14
Filed: 2016-03-30
Abstract: A base station is disclosed, which is capable of appropriately configuring the timings of data assignment, data transmission and reception, and feedback for a case where the DL and UL sTTI lengths are different from each other. In this base station (100), a transmission section (106) transmits a downlink signal using a first short transmission time interval (sTTI) shortened in length than a TTI and used for downlink; and a reception section (107) receives an uplink signal using a second sTTI shortened in length than the TTI and used for uplink. When the first sTTI is shorter in length than the second sTTI, the reception section (107) receives the uplink signal in the second sTTI positioned after a predetermined interval from the transmission timing of the downlink signal, the predetermined interval being configured based on the length of the first sTTI.
Patent EP-4250614-A2 (EP)
Title: Apparatus and method for transmitting and receiving packets in a mobile communication system supporting hybrid automatic repeat request
Inventor: KIM SOENG-HUN
IPC: H04L1/18
Filed: 2008-08-07
Abstract: The invention is directed to a method performed by a user equipment, UE, for receiving data in a communication system, the method comprising: identifying a hybrid automatic repeat request, HARQ, process identifier, ID, using a number of HARQ processes, interval information, and time information, wherein the number of HARQ processes is for a periodic resource allocation and the interval information is a periodic resource allocation interval, and wherein the time information is based on a system frame number, and receiving data for the HARQ process ID, in a first transmission, based on the periodic resource allocation and the interval information.
Patent EP-4303964-A2 (EP)
Inventor: DUONG HIEU MINH
IPC: H01M4/62
Filed: 2018-02-20
Abstract: An energy storage device can include a first electrode, a second electrode and a separator between the first electrode and the second electrode wherein the first electrode includes an electrochemically active material and a porous carbon material, and the second electrode includes elemental lithium metal and carbon particles. A method for fabricating an energy storage device can include forming a first electrode and a second electrode, and inserting a separator between the first electrode and the second electrode, where forming the first electrode includes combining an electrochemically active material and a porous carbon material, and forming the second electrode includes combining elemental lithium metal and a plurality of carbon particles.
Patent EP-0001395-A2 (EP)
Inventor: KNOPS HANS-JOACHIM DR
IPC: C07D207/404
Filed: 1978-08-29
Abstract: The compounds of the formula <IMAGE> in which R<1>, R<2>, R<3>, X and Y have the meaning indicated in the description, are obtained when succinic anhydrides are reacted with anilines in the presence of a diluent and the resulting hemiamides are cyclised in the presence of a dehydrating agent. The active compounds according to the invention have a broad spectrum of action and can be used against parasitic fungi, which infest above-ground parts of plants or attack the plants from the soil, and against pathogens which can be transferred by seeds. The active compounds according to the invention can be used to particularly good effect as plant protecting agents for controlling Botrytis and Pellicularia, and as cereal dressing agents, in particular against wheat bunt.
Patent EP-0017931-A2 (EP)
Title: 4H-3,1-Benzoxazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung unerwünschten Pflanzenwuchses
Inventor: HAMPRECHT GERHARD DR
IPC: C07D265/20
Filed: 1980-04-11
Abstract: Die vorliegende Erfindung betrifft neue 4H-3,1-Benzoxazinderivate der Formel I <IMAGE> in der R¹, R² und Y die in der Beschreibung genannten Bedeutungen haben, Verfahren zu ihrer Herstellung, Herbizide, die diese 4H-3,1-Benzoxazinderivate als Wirkstoffe enthalten, sowie neue substituierte Benzoylhalogenide, die als Ausgangsstoffe zur Herstellung von 4H-3,1-Benzoxazinderivaten der Formel I dienen.
Patent EP-0037039-A2 (EP)
Inventor: INOUYE TAMON
IPC: G16H10/60
Filed: 1981-03-20
Abstract: An image rexonstruction apparatus of the present invention comprises units (22, 23, 25, 26) for measuring projection data from a number of angular directions within an angular range less than 180° with respect to a subject (20), a unit (28) for performing parallel displacement of the projection data so that the subject may substantially be located within a specific region corresponding to said angular range, a unit (29) for calculating a Fourier coefficient for expanding the displaced that into a Fourier series, and units (31, 32, 33) for reconstructing a slice image of the subject by means of the calculated Fourier coefficient.
Patent EP-0042996-A2 (EP)
Inventor: OLEJAK GERHARD
IPC: G02B6/04
Filed: 1981-06-04
Abstract: 1. An optical communication cable having a core comprising optical cable elements and a synthetic resin sheath, in which the optical cable elements are twisted with synthetic resin threads, characterized in that : a) the optical cable elements (1) are twisted with a short lay with a bundle (3) of the synthetic resin threads also twisted with a short lay, b) the cable (4) consisting of optical cable elemnts (1) and threads (3) is enveloped by one or several layers of bands (5) of readily sliding synthetic resin, c) the synthetic resin sheath (8) provided around the core (6) consisting of optical cable elements (1), threads (3) and bands (5) is fibre-reinforced and its distance (7) with respect to the core (6) is from 5 to 50 % of the diameter of the core (6), d) at least one layer (9) of high-strength reinforcing fibres is processed in the synthetic resin sheath (8) with a long lay.
Patent EP-0037248-A2 (EP)
Inventor: NAKAJIMA TADANOBU
IPC: G03G21/10
Filed: 1981-03-25
Abstract: A method and device for recycling a residual developing material on a photosensitive material after transfer step in an electrostatic copying apparatus wherein there is provided a blade member (12) capable of sliding to contact with and separating from the photosensitive material (2) upstream with respect to a corona charger (4) for charging the photosensitive material (2) before exposuring step along the moving direction of the photosensitive material (2). The blade member (12) slides to contact with the photosensitive material (2) during the time when a latent image is formed onto the photosensitive material (2) in a developing step, and separates from the photosensitive material (2) during the time when the latent image is not formed in the copying operation. The developing material accumulated on the photosensitive material (2) by means of the blade member (12) in the exposuring step travels to be stored at a developing device (6) according to the movement of the photosensitive material (2).
Patent EP-0050007-A2 (EP)
Inventor: KAZUTOMO IMAHORI
IPC: C12N9/12
Filed: 1981-10-08
Abstract: A heat-resistant adenylate kinase is described whose activity after an incubation in a buffer solution at about 50°C for about 15 minutes is at least about 80% of the original activity prior to the incubation. This adenylate kinase can be obtained by cultivating a bacterium belonging to the genus Bacillus and collecting adenylate kinase from the resulting culture broth. This heat-resistant enzyme is very stable against heat and, therefore, after isolation, it can be stored for a long period of time compared with the conventional adenylate kinase.
Patent EP-0056610-A2 (EP)
Inventor: RIEGER HERBERT
IPC: B65D88/02
Filed: 1982-01-13
Abstract: The invention relates to a tank-type container for the processing of wine grape must, particularly a fermentation tank for red wine must. The tank is equipped with a slowly rotating agitator having a plurality of longitudinally spaced blades disposed the full length of its shaft extending parallel to the longitudinal axis of the tank. The invention resides in at least one section, preferably an outward section, of the cross-sectional area of the agitator blades parallel to the agitator shaft being larger than the cross-sectional area which is normal to the agitator shaft. The pomace cap floating on the surface of the juice is disintegrated and punched down into the body of the juice by means of the flat wide blade sections.
Patent EP-0084077-A2 (EP)
Inventor: CURTI EZIO
IPC: G03F7/16
Filed: 1982-03-19
Abstract: 1. Apparatus for automatically charging a film coater with boards for printed circuits, characterised in that a holder means (2) is provided above a stack of boards (9) and is adapted to reciprocate vertically with respect to the horizontal stack (9) ; said holder means (2) accommodates two parallel horizontal guide bars (5, 6) having at their opposite ends operable horizontal piston-and-cylinder units (12, 13), the piston rods (14, 15) of which are connected to parallel cross-members (18, 19) which are disposed in a horizontal plane, are perpendicular to the guide bars, and have adjustable grippers (22) at their free ends, said grippers being mounted to be elastically resiliently movable in a horizontal direction (30, 31) perpendicular to the cross-members and in a vertical direction (24, 26) with respect to the associated cross-members, said grippers also being constructed to hold a board between them at the board side edge surfaces ; and an operable and slidable roller table (32, 33) is provided parallel to each of the two horizontal cross-members (18, 19) bearing the grippers (22), the two roller tables being movable in a horizontal plane (9) out of an inoperative position into an operative position towards one another and towards the board situated therebetween, and back, in which operative position the boards (9) are transferred by the grippers to the roller tables (32, 33) and the boards are conveyed on by the roller tables engaging their side edge surfaces.
Patent EP-0064256-A2 (EP)
Inventor: MENCKE BURKHARD DR
IPC: C07D501/36
Filed: 1982-04-27
Abstract: Cephemderivate der allgemeinen Formel <IMAGE> gegen bakterielle Infektionen wirksame pharmazeutische Präparate, die solche Cephemderivate enthalten, Verfahren zur Herstellung der Cephemderivate und der pharmazeutischen Präparate und Verwendung der Cephemderivate zur Bekämpfung bakterieller Infektionen.
Patent EP-0073885-A2 (EP)
Inventor: BURKERT EDGAR DIPL-ING
IPC: H03L7/093
Filed: 1982-06-22
Abstract: The present invention relates to a control amplifier within a phase-locked loop (PLL). To be able to amplify the direct-voltage or low-voltage signal and the high-frequency signal independently of one another to a desired optimum degree, the control amplifier is formed of the parallel circuit of a low-frequency amplifier (NFV) and a high-frequency amplifier (HFV). <IMAGE>
Patent EP-0071749-A2 (EP)
Inventor: SCHOENBERG JULES E
IPC: C08G73/10
Filed: 1982-06-29
Abstract: Novel polyimides, optionally end-capped with polymerizable or inert groups, and the polyamic acid or ester intermediates thereof are prepared by reacting a tetracarboxylic acid compound (e.g. pyromellitic dianhydride or 3,3',4,4'-benzophenone tetracarboxylic acid dianhydride or its methyl diester) with diamines having the general formula
     wherein Z is oxygen or sulfur, X and/or Y are carbonyl or carbinol groups, the amine groups may be in the 2-, 3-, and/ or 4-position, and isomerism is present when X and/or Y is a carbinol group. The polyimides may be end-capped by reaction, during or after their formation, with polymerizable groups such as 3-aminophenyl acetylene or 3,6-endomethy- lene-1,2,3,6-tetrahydrophthalic anhydride. The diamines are novel classes of amines when Z is sulfur and when Z is oxygen and X, Y, or X and Y are carbinol groups.
Patent EP-0068647-A2 (EP)
Inventor: MANIS JACK JAY
IPC: C07H21/04
Filed: 1982-06-01
Abstract: A novel plasmid (pUC1061) is obtained by deletion of - 2.0 kilobases of DNA from the Streptomyces espinosus plasmid pUC6. This plasmid is useful as a cloning vehicle in recombinant DNA work. For example, using DNA methodology, a desired gene, for example, the glucose isomerase gene, can be inserted into the plasmid and the resulting plasmid can then be transformed into a suitable host microbe which, upon culturing, produces the desired glucose isomerase.
Patent EP-0070744-A2 (EP)
Inventor: SAKAI YOSHIO
IPC: H01L29/08
Filed: 1982-07-22
Abstract: An insulated gate field effect transistor has a well region (42) formed in a semiconductor substrate (41) of different conductivity type. The well region (42) has an opening in it so that a part of the substrate (47) extends within it. Source and drain regions (43, 44) are formed in the well region (42) on opposite sides of the opening, with the same conductivity type as the substrate (41). An insulated layer (45) is formed on the surface of the substrate between the source and drain regions (43, 44) and a gate electrode (46) is formed on the insulating layer (45). A potential is applied to the gate electrode (46) to reverse-bias the substrate-well junction and a depletion layer (48) is formed which includes the part of the substrate (41) between the source and drain regions (43, 44). This enables the transistor to have a small body effect, so that it may be operated with a constant current character.
Patent EP-0076044-A2 (EP)
Inventor: KNIRSCH FRANCO
IPC: B41M5/382
Filed: 1982-09-02
Abstract: The inked element in the form of a ribbon comprises a plastics support coated on one side with a thin layer (2 to 4mm) thermotransferable inking mixture which comprises, in addition to a pigment or dye, a binder of thermoplastic resin, in particular a styrene or terpene resin, a plasticizer and a softening compound constituted by one or more waxes in a percentage between 18 and 50%. The plasticizer is constituted by an ester of phthalic or phosphoric acid or another polymer.
Patent EP-0082098-A2 (EP)
Inventor: KENNINGTON KERRY S
IPC: E21B19/16
Filed: 1982-11-05
Abstract: A power tong unit (11) is shown which is operable as a closed head or open head unit. The jaws (147) of the tong unit are rotatable to an extended pipe gripping position from either of opposite directions to make-up or break-out pipe from a single retracted position. An improved reversal means (195, 197, 199, 203, 205, 207) controls the direction of rotation of the jaws (147) between the make-up and break-out positions.
Patent EP-0059158-A2 (EP)
Inventor: SCHWARZ NORBERT DR
IPC: C07D209/52
Filed: 1982-02-19
Abstract: Azaprostacyclins of Formula I    <IMAGE>  (I)  wherein R1 is hydrogen, alkyl, cycloalkyl, aryl, a heterocyclic residue, or a phenacyl residue optionally substituted on the phenyl ring by bromine, phenyl, alkoxy, or dialkoxy, W is a free or functionally modified carbonyl group or a   <IMAGE>   wherein R8 is hydrogen or alkyl of 1-5 carbon atoms and R9 is hydrogen or a readily cleavable ether or acyl residue and wherein the OR9-group can be in the  alpha - or  beta -position, R2 is a free or functionally modified hydroxy group, R3 and R4 each independently is hydrogen, alkyl of 1-5 carbon atoms, or fluorine, D is alkylene of 1-2 carbon atoms which can be substituted by alkyl groups of 1-5 carbon atoms, R5 is hydrogen or alkyl of 1-2 carbon atoms or, when D is alkylene of 1 or 2 carbon atoms, R5, together with R6, represents a bond, R6 and R7 each independently is hydrogen or alkyl of 1-2 carbon atoms, wherein R6(R7) is halogen when R7(R6), respectively, is alkyl of 1-2 carbon atoms or R5 and R7 each independently is hydrogen or alkyl of 1-2 carbon atoms when D and R6 together form a carbocyclic ring closed via (CH2)1-3 with D as -CH< and R6 as -CH2-, and, when R1 is hydrogen, the physiologically compatible salts thereof with bases, have valuable pharmacological properties, e.g., blood-pressure-lowering and bronchodilatory activities.